Jim Cramer, host of CNBC's "Mad Money," has been keeping tabs on Apple and its moves in healthcare since he suggested the iPhone maker buy Epic. Now he's proposing Apple merge with Dexcom, a company that develops continuous glucose-monitoring systems.
Since early January when Mr. Cramer suggested that JPMorgan Chase CEO Jamie Dimon should persuade Apple to join the healthcare venture his company started with Amazon and Berkshire Hathaway, he's been speculating about Apple's next healthcare project.
Mr. Cramer suggested Apple buy Verona, Wis.-based EHR vendor Epic, but that was met with pushback from several industry stakeholders who noted Epic CEO Judy Faulkner's widely known stance on keep the company private.
Responding to the backlash Jan. 23, Mr. Cramer suggested that Apple could instead pursue Epic's competitor, Cerner, adding that "Apple is uniquely positioned to revolutionize the electronic health records business," regardless of whether it pursues an acquisition.
Now, Mr. Cramer is suggesting Apple merge with Dexcom.
"When I talk about what Apple could buy that would really help them in the healthcare segment, I mistakenly neglected that if they could somehow do a merger with Dexcom, that would be really unbelievable, too," he said.
Click here to access Mr. Cramer's CNBC analysis.